Combined hormonal contraceptive (CHC) use among obese women and contraceptive effectiveness: a systematic review

被引:21
|
作者
Dragoman, Monica V. [1 ]
Simmons, Katharine B. [2 ,3 ]
Paulen, Melissa E. [4 ]
Curtis, Kathryn M. [2 ]
机构
[1] WHO, Dept Reprod Hlth & Res, Geneva, Switzerland
[2] Ctr Dis Control & Prevent, Div Reprod Hlth, Atlanta, GA USA
[3] Univ N Carolina, Dept Obstet & Gynecol, Chapel Hill, NC USA
[4] Indiana Univ, Dept Obstet & Gynecol, Indianapolis, IN 46204 USA
关键词
Combined hormonal contraception; Obesity; Contraceptive effectiveness; Oral contraception; BODY-MASS INDEX; NATIONAL-SURVEY; FAILURE; WEIGHT; EFFICACY; COHORT; RISK;
D O I
10.1016/j.contraception.2016.10.010
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To evaluate from the literature whether combined hormonal contraception (CHC), including combined oral contraception pills (COCs), transdermal patch, vaginal ring or combined injectables, have different effectiveness or failure rates by body weight or body mass index (BMI). Study design: We searched PubMed and the Cochrane Library databases for all articles in all languages published between inception and February 2016, for evidence relevant to body weight or BMI, CHC use and contraceptive effectiveness. The quality of each individual study was assessed using the system for evaluating evidence developed by the United States Preventive Services Task Force. Results: From 2874 articles, we identified 15 reports for inclusion, all of fair to poor quality. Fourteen studies measured the association of obesity status and contraceptive failure among COC users. Three fair quality and one poor quality study reported increased COC failure among a heterogeneous population of overweight and obese women compared with normal weight women, while eight fair quality and two poor quality studies did not find an association. Two fair quality studies reported on contraceptive transdermal patches. One pooled analysis described a higher proportion of pregnancies among women using the patch who weighed >= 90 kg; another secondary analysis suggested BMI>30 was associated with increased failure. No studies directly compared contraceptive effectiveness using the combined vaginal ring or combined injectable. Conclusion: Current available evidence addressing the risk of CHC failure in obese compared to normal weight women is limited to fair and poor quality studies. Studies of COCs show mixed results, though absolute differences in COC failure by body weight and BMI are small. Based on limited evidence, it appears that increasing body weight and BMI may contribute to decreasing contraceptive patch effectiveness. (C) 2017 Published by Elsevier Inc.
引用
收藏
页码:117 / 129
页数:13
相关论文
共 50 条
  • [31] Effect of hormonal contraceptive methods on HIV disease progression: a systematic review
    Phillips, Sharon J.
    Curtis, Kathryn M.
    Polis, Chelsea B.
    AIDS, 2013, 27 (05) : 787 - 794
  • [32] Combined Hormonal Contraceptive Usage in Women With COVID-19
    Kurdoglu, Zehra
    INTERNATIONAL JOURNAL OF WOMENS HEALTH AND REPRODUCTION SCIENCES, 2021, 9 (02): : 84 - 85
  • [33] An updated systematic review of epidemiological evidence on hormonal contraceptive methods and HIV acquisition in women
    Polis, Chelsea B.
    Curtis, Kathryn M.
    Hannaford, Philip C.
    Phillips, Sharon J.
    Chipato, Tsungai
    Kiarie, James N.
    Westreich, Daniel J.
    Steyn, Petrus S.
    AIDS, 2016, 30 (17) : 2665 - 2683
  • [34] Hormonal contraceptive methods and risk of HIV acquisition in women: a systematic review of epidemiological evidence
    Polis, Chelsea B.
    Phillips, Sharon J.
    Curtis, Kathryn M.
    Westreich, Daniel J.
    Steyn, Petrus S.
    Raymond, Elizabeth
    Hannaford, Philip
    Turner, Abigail Norris
    CONTRACEPTION, 2014, 90 (04) : 360 - 390
  • [35] Assessing the impact of contraceptive use on mental health among women of reproductive age - a systematic review
    Jahanfar, Shayesteh
    Mortazavi, Julie
    Lapidow, Amy
    Cu, Cassandra
    Al Abosy, Jude
    Morris, Katherine
    Becerra-Mateus, Juan Camilo
    Andrenacci, Paola
    Badawy, Marwa
    Steinfeldt, Meredith
    Maurer, Olivia
    Jiang, Bohang
    Ali, Moazzam
    BMC PREGNANCY AND CHILDBIRTH, 2024, 24 (01)
  • [36] Pregnancy preferences and contraceptive use among US women
    Samari, Goleen
    Foster, Diana G.
    Ralph, Lauren J.
    Rocca, Corinne H.
    CONTRACEPTION, 2020, 101 (02) : 79 - 85
  • [37] Systematic Review of Contraceptive Use Among Sex Workers in North America
    Zemlak, Jessica L.
    Bryant, Anna P.
    Jeffers, Noelene K.
    JOGNN-JOURNAL OF OBSTETRIC GYNECOLOGIC AND NEONATAL NURSING, 2020, 49 (06): : 537 - 548
  • [38] Contraceptive use and contraceptive counselling interventions for women of reproductive age with cancer: a systematic review and meta-analysis
    Harris, Melissa L. L.
    Feyissa, Tesfaye R. R.
    Bowden, Nikola A. A.
    Gemzell-Danielsson, Kristina
    Loxton, Deborah
    BMC MEDICINE, 2022, 20 (01):
  • [39] Hormonal contraceptive use in Australian women: Who is using what?
    Skiba, Marina A.
    Islam, Rakibul M.
    Bell, Robin J.
    Davis, Susan R.
    AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2019, 59 (05) : 717 - 724
  • [40] Ovarian Suppression in Normal-Weight and Obese Women During Oral Contraceptive Use A Randomized Controlled Trial
    Westhoff, Carolyn L.
    Torgal, Anupama H.
    Mayeda, Elizabeth R.
    Stanczyk, Frank Z.
    Lerner, Jodi P.
    Benn, Emma K. T.
    Paik, Myunghee
    OBSTETRICS AND GYNECOLOGY, 2010, 116 (02) : 275 - 283